Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
426 Ergebnisse
| JE0U19 | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,700 % | 0,499 | -0,118 | 5,629 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE11YS | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 42,376 % | 0,560 | -0,100 | 4,191 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE84GW | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 41,524 % | 0,583 | -0,085 | 3,671 | 17.06.2027 | 0,100 | JP Morgan | ||
| JY3LSJ | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 44,630 % | 0,370 | -0,259 | 12,177 | 21.08.2026 | 0,100 | JP Morgan | ||
| MJ860V |  | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,163 % | 0,524 | -0,012 | 5,534 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9KV0 | | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 41,386 % | 0,583 | -0,008 | 3,682 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5JNZ | | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,930 % | 0,462 | -0,018 | 8,757 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN04AF | | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 44,178 % | 0,619 | -0,007 | 2,876 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6FTB | | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 41,751 % | 0,536 | -0,010 | 4,353 | 19.03.2027 | 0,010 | Morgan Stanley | |
| SX5K5E | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 39,837 % | 0,507 | -0,107 | 5,286 | 15.01.2027 | 0,100 | Société Générale | ||
| SX5KSN | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 41,049 % | 0,421 | -0,179 | 9,193 | 18.09.2026 | 0,100 | Société Générale | ||
| FA53KA | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 39,732 % | 0,495 | -0,115 | 5,769 | 18.12.2026 | 0,100 | Société Générale | ||
| FD1ZF8 | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 41,320 % | 0,536 | -0,096 | 4,390 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58U1 | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,487 % | 0,564 | -0,082 | 3,823 | 17.06.2027 | 0,100 | Société Générale | ||
| FE58U6 | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,416 % | 0,579 | -0,072 | 3,429 | 17.09.2027 | 0,100 | Société Générale | ||
| FE58VJ | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,118 % | 0,603 | -0,064 | 3,057 | 21.01.2028 | 0,100 | Société Générale | ||
| FE58VA | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 40,300 % | 0,597 | -0,066 | 3,140 | 17.12.2027 | 0,100 | Société Générale | ||
| VJ5DDF | | Vertex Pharmaceuticals Inc./OS/Call [500]/VONT | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 37,394 % | 0,489 | -0,109 | 6,115 | 18.12.2026 | 0,100 | Vontobel | |
| VY41YX | | Vertex Pharmaceuticals Inc./OS/Call [500]/VONT | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 41,831 % | 0,583 | -0,086 | 3,651 | 17.06.2027 | 0,100 | Vontobel | |
| VY5LY8 | | Vertex Pharmaceuticals Inc./OS/Call [500]/VONT | - | - | 500,000 | call | Vertex Pharmaceuticals Inc. | - | 37,394 % | 0,454 | -0,170 | 9,591 | 18.09.2026 | 0,100 | Vontobel | |
| GW3T1R | Vertex Pharmaceuticals Inc./OS/Call [520]/GOLDS | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 37,041 % | 0,442 | -0,098 | 6,001 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW3ZYA | Vertex Pharmaceuticals Inc./OS/Call [520]/GOLDS | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 38,092 % | 0,502 | -0,091 | 4,845 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW5B2C | Vertex Pharmaceuticals Inc./OS/Call [520]/GOLDS | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 37,095 % | 0,511 | -0,077 | 4,316 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| JZ96U2 | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 42,353 % | 0,376 | -0,179 | 9,293 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE1XVC | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 39,746 % | 0,408 | -0,144 | 7,986 | 16.10.2026 | 0,100 | JP Morgan | ||
| JE0WCN | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 40,335 % | 0,438 | -0,114 | 6,035 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE0URA | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 41,815 % | 0,494 | -0,096 | 4,533 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE84H6 | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 41,047 % | 0,525 | -0,083 | 3,927 | 17.06.2027 | 0,100 | JP Morgan | ||
| JY0YG1 | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 40,509 % | 0,482 | -0,110 | 5,331 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY3QF9 | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 43,375 % | 0,306 | -0,230 | 13,214 | 21.08.2026 | 0,100 | JP Morgan | ||
| SX5K5F | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 38,617 % | 0,449 | -0,102 | 5,752 | 15.01.2027 | 0,100 | Société Générale | ||
| FE1AXQ | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 39,335 % | 0,432 | -0,111 | 6,202 | 18.12.2026 | 0,100 | Société Générale | ||
| FE1AXV | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 40,828 % | 0,487 | -0,094 | 4,654 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58HD | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 40,690 % | 0,326 | -0,161 | 10,253 | 18.09.2026 | 0,100 | Société Générale | ||
| FE58U2 | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 40,029 % | 0,522 | -0,081 | 4,019 | 17.06.2027 | 0,100 | Société Générale | ||
| FE58VK | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 39,659 % | 0,571 | -0,064 | 3,180 | 21.01.2028 | 0,100 | Société Générale | ||
| VH6279 | | Vertex Pharmaceuticals Inc./OS/Call [520]/VONT | - | - | 520,000 | call | Vertex Pharmaceuticals Inc. | - | 37,702 % | 0,442 | -0,099 | 5,910 | 15.01.2027 | 0,100 | Vontobel | |
| GW527B | Vertex Pharmaceuticals Inc./OS/Call [540]/GOLDS | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 36,953 % | 0,382 | -0,093 | 6,396 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW90LJ | Vertex Pharmaceuticals Inc./OS/Call [540]/GOLDS | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 37,667 % | 0,426 | -0,085 | 5,282 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW95H1 | Vertex Pharmaceuticals Inc./OS/Call [540]/GOLDS | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 36,971 % | 0,465 | -0,075 | 4,524 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| JE05DP | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 39,082 % | 0,295 | -0,122 | 9,199 | 16.10.2026 | 0,100 | JP Morgan | ||
| JE0U18 | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 40,175 % | 0,406 | -0,112 | 6,236 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY0EK3 | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 40,182 % | 0,402 | -0,102 | 5,829 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY30EE | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 41,427 % | 0,447 | -0,094 | 4,780 | 19.03.2027 | 0,100 | JP Morgan | ||
| JY3LSB | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 44,785 % | 0,177 | -0,166 | 15,306 | 21.08.2026 | 0,100 | JP Morgan | ||
| SX5K5G | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 39,066 % | 0,397 | -0,099 | 5,999 | 15.01.2027 | 0,100 | Société Générale | ||
| FE1AXL | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 40,223 % | 0,240 | -0,134 | 11,439 | 18.09.2026 | 0,100 | Société Générale | ||
| FE58HE | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 39,219 % | 0,375 | -0,105 | 6,592 | 18.12.2026 | 0,100 | Société Générale | ||
| FE58HJ | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 39,874 % | 0,462 | -0,093 | 4,855 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58U3 | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540,000 | call | Vertex Pharmaceuticals Inc. | - | 39,613 % | 0,480 | -0,080 | 4,217 | 17.06.2027 | 0,100 | Société Générale |